(Z)-Desbutyl lumefantrine

CAS : 355841-11-1

Ref. 3D-FPA84111

Informations sur le produit

• Nom: (Z)-Desbutyl lumefantrine
• Synonymes: (9Z)-α-[(Butylamino)methyl]-2,7-dichloro-9-[(4-chlorophenyl)methylene]-9H-fluorene-4-methanol, Desbutyl-benflumetol, Desbutyllumefantrine, 9H-Fluorene-4-methanol, α-[(butylamino)methyl]-2,7-dichloro-9-[(4-chlorophenyl)methylene]-, (9Z)-

Description

(Z)-Desbutyl lumefantrine (DBL) is a drug used for the treatment and prevention of malaria. The drug is a prodrug that is converted to lumefantrine in vivo. DBL has significant interactions with other drugs, such as trifluoroacetic acid, which may lead to toxic effects or therapeutic failure. DBL should not be taken by nonpregnant women or women who are pregnant, as it can cause birth defects in the fetus. Pharmacokinetics of DBL were studied in healthy adult subjects and found to have linear pharmacokinetic properties in the concentration-time curve. It had a mean elimination half-life of 5 hours, an oral bioavailability of 98%, and low systemic clearance (0.2 L/h).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 472.8 g/mol
• Formule: C₂₆H₂₄Cl₃NO
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder